These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15641869)

  • 41. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
    Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.
    Mourilhe P; Stokes PE
    Drug Saf; 1998 Jan; 18(1):57-82. PubMed ID: 9466088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective Serotonin Reuptake Inhibitor Use and Risk of Gastrointestinal and Intracranial Bleeding.
    Yuet WC; Derasari D; Sivoravong J; Mason D; Jann M
    J Am Osteopath Assoc; 2019 Feb; 119(2):102-111. PubMed ID: 30688347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma.
    Chen HY; Lin CL; Lai SW; Kao CH
    J Clin Psychiatry; 2016 Jun; 77(6):e692-6. PubMed ID: 27135704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting.
    Kim DH; Daskalakis C; Whellan DJ; Whitman IR; Hohmann S; Medvedev S; Kraft WK
    Am J Cardiol; 2009 May; 103(10):1391-5. PubMed ID: 19427434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
    Hall WD; Lucke J
    Aust N Z J Psychiatry; 2006; 40(11-12):941-50. PubMed ID: 17054562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of serotonin reuptake by antidepressants and cerebral microbleeds in the general population.
    Aarts N; Akoudad S; Noordam R; Hofman A; Ikram MA; Stricker BH; Visser LE; Vernooij MW
    Stroke; 2014 Jul; 45(7):1951-7. PubMed ID: 24876079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between Selective Serotonin Reuptake Inhibitor Therapy and Suicidality: Analysis of U.S. Food and Drug Administration Adverse Event Reporting System Data.
    Umetsu R; Abe J; Ueda N; Kato Y; Matsui T; Nakayama Y; Kinosada Y; Nakamura M
    Biol Pharm Bull; 2015; 38(11):1689-99. PubMed ID: 26521821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effects of Pretreatment versus De Novo Treatment with Selective Serotonin Reuptake Inhibitors on Short-term Outcome after Acute Ischemic Stroke.
    Siepmann T; Kepplinger J; Zerna C; Schatz U; Penzlin AI; Pallesen LP; Illigens BM; Weidner K; Reichmann H; Puetz V; Bodechtel U; Barlinn K
    J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1886-92. PubMed ID: 26099557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience.
    DeVane CL; Sallee FR
    J Clin Psychiatry; 1996 Feb; 57(2):55-66. PubMed ID: 8591970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of selective serotonin reuptake inhibitors antidepressants and bleeding risk in breast cosmetic surgery.
    Basile FV; Basile AR; Basile VV
    Aesthetic Plast Surg; 2013 Jun; 37(3):561-6. PubMed ID: 23571783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
    Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M
    Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.
    Jakobsen JC; Katakam KK; Schou A; Hellmuth SG; Stallknecht SE; Leth-Møller K; Iversen M; Banke MB; Petersen IJ; Klingenberg SL; Krogh J; Ebert SE; Timm A; Lindschou J; Gluud C
    BMC Psychiatry; 2017 Feb; 17(1):58. PubMed ID: 28178949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antidepressant treatment for postnatal depression.
    Brown JVE; Wilson CA; Ayre K; Robertson L; South E; Molyneaux E; Trevillion K; Howard LM; Khalifeh H
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013560. PubMed ID: 33580709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter?
    Chen Y; Guo JJ; Patel NC
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):196-202. PubMed ID: 19115419
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study.
    Douglas I; Smeeth L; Irvine D
    Br J Clin Pharmacol; 2011 Jan; 71(1):116-20. PubMed ID: 21143507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial.
    Quinn GR; Hellkamp AS; Hankey GJ; Becker RC; Berkowitz SD; Breithardt G; Fava M; Fox KAA; Halperin JL; Mahaffey KW; Nessel CC; Patel MR; Piccini JP; Singer DE
    J Am Heart Assoc; 2018 Aug; 7(15):e008755. PubMed ID: 30371223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.